Article

Board members include industry leaders, investors

Alimera Sciences Inc. has added two notable names in the ophthalmology industry to its board of directors.

Alimera Sciences Inc. has added two notable names in the ophthalmology industry to its board of directors.

Steve Martin, JD, a former president of CIBA Vision Corp. USA and founder of its optics and ophthalmics business, and Calvin W. Roberts, MD, clinical professor of ophthalmology at Weill Medical College at Cornell University, joined the board in July.

Martin is chief executive officer and partner at Hi Tech Partners in Atlanta, where he advises early-stage technology firms.

They join representatives from each of the four venture capital firms that invested in Alimera Sciences. Intersouth Partners led financing with more than $6 million, an amount matched by BA Venture Partners, Domain Associates, and Polaris Venture Partners.OT

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.